期刊文献+

解读中国帕金森病治疗指南 被引量:9

The interpretation of Chinese guideline for the treatment of Parkinson's disease
原文传递
导出
摘要 中华医学会神经病学分会在2009年发表了《中国帕金森病治疗指南(第二版)》。该指南根据国内外循证医学证据对于帕金森病治疗的有关内容进行了分析,具体包括药物治疗的原则、开始治疗的时机、选择药物的依据、不同阶段的治疗策略。对于中晚期帕金森病合并运动并发症的治疗进行了详细的总结;提出了治疗帕金森病非运动症状的初步建议;对于帕金森病手术治疗的适应证、时机等进行了分析。 The Chinese guideline of Parkinson's disease (PD) make evidence-based treatment recommendations for the medical and surgical treatment of patients with Parkinson disease. The available evidence establish superiority of continuous dopaminergic stimulation in reducing levodopa-induced motor fluctuations and dyskinesia. Nonmotor symptoms ( sleep dysfunction, sensory symptoms, autonomic dysfunction, mood disorders, and cognitive abnormalities) in Parkinson disease are a major cause of morbidity. This evidence-based practice parameter evaluates treatment options for the nonmotor symptoms of PD. Deep brain stimulation of the STN may be considered to improve motor function and reduce off time,dyskinesia,and medication usage.
作者 冯涛
出处 《中国实用内科杂志》 CAS CSCD 北大核心 2010年第11期986-988,共3页 Chinese Journal of Practical Internal Medicine
关键词 帕金森病 药物 治疗 Parkinson's disease treatment drug
  • 相关文献

参考文献10

  • 1中国帕金森病治疗指南(第二版)[J].中华神经科杂志,2009,42(5):352-355. 被引量:171
  • 2Horstink M,Tolosa E, Bonuccelli U, et al. Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies and the Movement Disorder Society-European Section. Part I : early ( uncomplicated) Parkinson's disease [ J]. Eur J Neurol, 2006, 13 ( 11 ) : 1170-1185.
  • 3Baker WL, Silver D, White CM, et al. Dopamine agonists in the treatment of early Parkinson's disease: a meta-analysis [ J ]. Parkinsonism Relat Disord ,2009,15 (4) :287 - 294.
  • 4Simonis G, Fuhrmann JT,Strasser RH. Meta-analysis of heart valve abnormalities in Parkinson's disease patients treated with dopamine agonists[ J]. Mov Disord ,2007,22( 13 ) : 1936 - 1942.
  • 5Horstink M, Tolosa E, Bonuccelli U, et al. Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies (EFNS) and the Movement Disorder Society-European Section (MDS-ES). Part II: late (complicated) Parkinson's disease [ J ]. Eur J Neurol, 2006,13 ( 11 ) :1186 - 1202.
  • 6冯涛,王拥军.持续性多巴胺能刺激治疗帕金森病的研究进展[J].临床神经病学杂志,2008,21(4):315-317. 被引量:4
  • 7Pahwa R, Factor SA, Lyons KE, et al. Practice parameter: treatment of Parkinson disease with motor fluctuations and dyskinesia (an evidence-based review) : report of the Quality Standards Subcommittee of the American Academy of Neurology[ J ]. Neurology, 2006,66 (7) :983 - 995.
  • 8Aarsland D, Emre M, Lees A, et al. Practice parameter: evaluation and treatment of depression, psychosis, and dementia in Parkinson disease ( an evidence-based review) : report of the Quality Stand- ards Subcommittee of the American Academy of Neurology [ J ]. Neurology ,2007,68 ( 1 ) :80.
  • 9Zesiewicz TA, Sullivan KL, Arnulf I, et al. Practice parameter: treatment of nonmotor symptoms of Parkinson disease : report of the Quality Standards Subcommittee of the American Academy of Neurology[ J]. Neurology,2010,74( 11 ) :924 -931.
  • 10Benabid AL, Chabardes S, Mitrofanis J, et al. Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease [ J ]. Lancet Neurol,2009,8 ( 1 ) :67 - 81.

二级参考文献35

  • 1陈生弟.帕金森病治疗指南[J].中华神经科杂志,2006,39(6):409-412. 被引量:102
  • 2温洪波,张振馨,罗毅,陈生弟,蒋雨平,张小英,孙相如,王新德,姚晨.普拉克索治疗帕金森病的多中心、随机、双盲、溴隐亭对照临床疗效和安全性研究[J].中华神经科杂志,2006,39(9):604-608. 被引量:63
  • 3Parkinson Study Group. Effects of tocopherol and deprenyl on the progression of disability in early Parkinson' s disease. N Engl J Med, 1993, 328 : 176-183.
  • 4Hauser RA, Lew MF, Hurtig HI, et al. Long-term outcome of early versus delayed rasagiline treatment in early Parkinson' s disease. Mov Disord, 2008, 24:562-571.
  • 5Bonuccelli U, Pavese N. Role of dopamine agonists in Parkinson' s disease : an update. Expert Rev Neurother, 2007, 7 : 1391-1399.
  • 6Shults CW, Oakes D, Kieburtz K, et al. Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline. Arch Neurol, 2002, 59 : 1541-1550.
  • 7Albin RL, Frey KA. Initial agonist treatment of Parkinson disease : a critique. Neurology, 2003, 60 : 390-394.
  • 8Olanow W, Schapira AH, Rascol O. Continuous dopamine- receptor stimulation in early Parkinson' s disease. Trends Neurosci, 2000, 23 ( 10 Suppl) : Sl17-126.
  • 9Olanow CW, Watts RL, Koller WC. An algorithm ( decision tree) for the management of Parkinson' s disease ( 2001 ) : treatment guidelines. Neurology, 2001,56 ( 11 Suppl 5 ) : S1-S88.
  • 10Horstink M, Tolosa E, Bonuccelli U, et al. Review of the therapeutic management of Parkinson' s disease. Report of a joint task force of the European Federation of Neurological Societies and the Movement Disorder Society-European Section. Part I : early (uncomplicated) Parkinson' s disease. Eur J Neurol, 2006, 13 : 1170-1185.

共引文献172

同被引文献157

引证文献9

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部